Depreciation of CRESCENT BIOPHARMA, INC. from 31 Dec 2012 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
CRESCENT BIOPHARMA, INC. annual and quarterly Depreciation in USD history and change rate from 31 Dec 2012 to 31 Dec 2025.
  • CRESCENT BIOPHARMA, INC. Depreciation for the quarter ending 31 Dec 2024 was $0, a 100% decline year-over-year.
  • CRESCENT BIOPHARMA, INC. annual Depreciation for 2025 was $84,000, a 139% increase from 2024.
  • CRESCENT BIOPHARMA, INC. annual Depreciation for 2024 was $35,174, a 77% decline from 2023.
  • CRESCENT BIOPHARMA, INC. annual Depreciation for 2023 was $153,301, a 26% decline from 2022.
Source SEC data
View on sec.gov
Depreciation, Annual (USD)
Depreciation, YoY Annual Change (%)
Depreciation, Trailing 12 Months (USD)
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Change (%)

CRESCENT BIOPHARMA, INC. Annual Depreciation (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2025 $84,000 +$48,826 +139% 01 Jan 2025 31 Dec 2025 10-K 26 Feb 2026 2025 FY
2024 $35,174 -$118,127 -77% 01 Jan 2024 31 Dec 2024 10-K 13 Feb 2025 2024 FY
2023 $153,301 -$53,844 -26% 01 Jan 2023 31 Dec 2023 10-K 13 Feb 2025 2024 FY
2022 $207,145 -$57,455 -22% 01 Jan 2022 31 Dec 2022 10-K 27 Mar 2024 2023 FY
2021 $264,600 -$6,154 -2.3% 01 Jan 2021 31 Dec 2021 10-K 27 Mar 2024 2023 FY
2020 $270,754 -$8,480 -3% 01 Jan 2020 31 Dec 2020 10-K 29 Mar 2023 2022 FY
2019 $279,234 +$4,111 +1.5% 01 Jan 2019 31 Dec 2019 10-K 03 Mar 2022 2021 FY
2018 $275,123 +$11,582 +4.4% 01 Jan 2018 31 Dec 2018 10-K 02 Mar 2021 2020 FY
2017 $263,541 +$73,001 +38% 01 Jan 2017 31 Dec 2017 10-K 28 Feb 2020 2019 FY
2016 $190,540 -$944 -0.49% 01 Jan 2016 31 Dec 2016 10-K 06 Mar 2019 2018 FY
2015 $191,484 +$32,776 +21% 01 Jan 2015 31 Dec 2015 10-K 06 Mar 2018 2017 FY
2014 $158,708 +$25,657 +19% 01 Jan 2014 31 Dec 2014 10-K 01 Mar 2017 2016 FY
2013 $133,051 +$33,128 +33% 01 Jan 2013 31 Dec 2013 10-K 29 Feb 2016 2015 FY
2012 $99,923 01 Jan 2012 31 Dec 2012 10-K 16 Mar 2015 2014 FY

CRESCENT BIOPHARMA, INC. Quarterly Depreciation (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q4 2024 $0 -$23,296 -100% 20 Sep 2024 31 Dec 2024 10-K 26 Feb 2026 2025 FY
Q3 2024 $0 -$42,747 -100% 20 Sep 2024 30 Sep 2024 10-Q 06 Nov 2025 2025 Q3
Q1 2024 $124,082 $14,620 -$29,219 -67% 01 Jan 2024 31 Mar 2024 10-Q 14 May 2025 2025 Q1
Q4 2023 $153,301 $23,296 -$22,421 -49% 01 Oct 2023 31 Dec 2023 10-K 13 Feb 2025 2024 FY
Q3 2023 $175,722 $42,747 -$4,600 -9.7% 01 Jul 2023 30 Sep 2023 10-Q 03 Nov 2023 2023 Q3
Q2 2023 $180,322 $43,419 -$11,354 -21% 01 Apr 2023 30 Jun 2023 10-Q 02 Aug 2023 2023 Q2
Q1 2023 $191,676 $43,839 -$15,469 -26% 01 Jan 2023 31 Mar 2023 10-Q 09 May 2024 2024 Q1
Q4 2022 $207,145 $45,717 -$15,925 -26% 01 Oct 2022 31 Dec 2022 10-K 27 Mar 2024 2023 FY
Q3 2022 $223,070 $47,347 -$20,038 -30% 01 Jul 2022 30 Sep 2022 10-Q 03 Nov 2023 2023 Q3
Q2 2022 $243,108 $54,773 -$12,712 -19% 01 Apr 2022 30 Jun 2022 10-Q 02 Aug 2023 2023 Q2
Q1 2022 $255,820 $59,308 -$8,780 -13% 01 Jan 2022 31 Mar 2022 10-Q 03 May 2023 2023 Q1
Q4 2021 $264,600 $61,642 -$6,713 -9.8% 01 Oct 2021 31 Dec 2021 10-K 27 Mar 2024 2023 FY
Q3 2021 $271,313 $67,385 +$858 +1.3% 01 Jul 2021 30 Sep 2021 10-Q 09 Nov 2022 2022 Q3
Q2 2021 $270,455 $67,485 -$196 -0.29% 01 Apr 2021 30 Jun 2021 10-Q 03 Aug 2022 2022 Q2
Q1 2021 $270,651 $68,088 -$103 -0.15% 01 Jan 2021 31 Mar 2021 10-Q 28 Apr 2022 2022 Q1
Q4 2020 $270,754 $68,355 +$1,535 +2.3% 01 Oct 2020 31 Dec 2020 10-K 29 Mar 2023 2022 FY
Q3 2020 $269,219 $66,527 -$4,255 -6% 01 Jul 2020 30 Sep 2020 10-Q 02 Nov 2021 2021 Q3
Q2 2020 $273,474 $67,681 -$3,510 -4.9% 01 Apr 2020 30 Jun 2020 10-Q 05 Aug 2021 2021 Q2
Q1 2020 $276,984 $68,191 -$2,250 -3.2% 01 Jan 2020 31 Mar 2020 10-Q 03 May 2021 2021 Q1
Q4 2019 $279,234 $66,820 -$1,509 -2.2% 01 Oct 2019 31 Dec 2019 10-K 03 Mar 2022 2021 FY
Q3 2019 $280,743 $70,782 +$2,305 +3.4% 01 Jul 2019 30 Sep 2019 10-Q 06 Nov 2020 2020 Q3
Q2 2019 $278,438 $71,191 +$1,631 +2.3% 01 Apr 2019 30 Jun 2019 10-Q 31 Jul 2020 2020 Q2
Q1 2019 $276,807 $70,441 +$1,684 +2.4% 01 Jan 2019 31 Mar 2019 10-Q 01 May 2020 2020 Q1
Q4 2018 $275,123 $68,329 -$1,239 -1.8% 01 Oct 2018 31 Dec 2018 10-K 02 Mar 2021 2020 FY
Q3 2018 $276,362 $68,477 -$1,583 -2.3% 01 Jul 2018 30 Sep 2018 10-Q 07 Nov 2019 2019 Q3
Q2 2018 $277,945 $69,560 -$14 -0.02% 01 Apr 2018 30 Jun 2018 10-Q 01 Aug 2019 2019 Q2
Q1 2018 $277,959 $68,757 +$14,418 +27% 01 Jan 2018 31 Mar 2018 10-Q 02 May 2019 2019 Q1
Q4 2017 $263,541 $69,568 +$18,777 +37% 01 Oct 2017 31 Dec 2017 10-K 28 Feb 2020 2019 FY
Q3 2017 $244,764 $70,060 +$24,252 +53% 01 Jul 2017 30 Sep 2017 10-Q 02 Nov 2018 2018 Q3
Q2 2017 $220,512 $69,574 +$22,867 +49% 01 Apr 2017 30 Jun 2017 10-Q 09 Aug 2018 2018 Q2
Q1 2017 $197,645 $54,339 +$7,105 +15% 01 Jan 2017 31 Mar 2017 10-Q 03 May 2018 2018 Q1
Q4 2016 $190,540 $50,791 +$1,724 +3.5% 01 Oct 2016 31 Dec 2016 10-K 06 Mar 2019 2018 FY
Q3 2016 $188,816 $45,808 -$6,074 -12% 01 Jul 2016 30 Sep 2016 10-Q 08 Nov 2017 2017 Q3
Q2 2016 $194,890 $46,707 +$417 +0.9% 01 Apr 2016 30 Jun 2016 10-Q 03 Aug 2017 2017 Q2
Q1 2016 $194,473 $47,234 +$2,989 +6.8% 01 Jan 2016 31 Mar 2016 10-Q 08 May 2017 2017 Q1
Q4 2015 $191,484 $49,067 +$4,620 +10% 01 Oct 2015 31 Dec 2015 10-K 06 Mar 2018 2017 FY
Q3 2015 $186,864 $51,882 +$11,093 +27% 01 Jul 2015 30 Sep 2015 10-Q 04 Nov 2016 2016 Q3
Q2 2015 $175,771 $46,290 +$7,438 +19% 01 Apr 2015 30 Jun 2015 10-Q 04 Aug 2016 2016 Q2
Q1 2015 $168,333 $44,245 +$9,625 +28% 01 Jan 2015 31 Mar 2015 10-Q 04 May 2016 2016 Q1
Q4 2014 $158,708 $44,447 +$9,020 +25% 01 Oct 2014 31 Dec 2014 10-K 01 Mar 2017 2016 FY
Q3 2014 $149,688 $40,789 +$7,483 +22% 01 Jul 2014 30 Sep 2014 10-Q 12 Nov 2015 2015 Q3
Q2 2014 $142,205 $38,852 +$6,474 +20% 01 Apr 2014 30 Jun 2014 10-Q 06 Aug 2015 2015 Q2
Q1 2014 $135,731 $34,620 +$2,680 +8.4% 01 Jan 2014 31 Mar 2014 10-Q 05 May 2015 2015 Q1
Q4 2013 $133,051 $35,427 01 Oct 2013 31 Dec 2013 10-K 29 Feb 2016 2015 FY
Q3 2013 $33,306 01 Jul 2013 30 Sep 2013 10-Q 31 Oct 2014 2014 Q3
Q2 2013 $32,378 01 Apr 2013 30 Jun 2013 10-Q 31 Jul 2014 2014 Q2
Q1 2013 $31,940 01 Jan 2013 31 Mar 2013 10-Q 09 May 2014 2014 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.